Tissue engineering and regenerative medicine: bench to bedside in urology. Preface.
作者信息
Damaser Margot S, Sievert Karl-Dietrich
机构信息
Dept of Biomedical Engineering, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA; Advanced Platform Technology Center of Excellence, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA.
Dept of Urology, UKT, University of Tübingen, Tübingen, Germany; Dept of Urology, UKSH, Campus Lübeck, University of Lübeck, Lübeck, Germany; Dept of Urology and Andrology, Uro-Oncology, Neurourology, Incontinence and Reconstructive Urology, Paracelsus Medical University, Salzburg, Austria.
出版信息
Adv Drug Deliv Rev. 2015 Mar;82-83:v-vii. doi: 10.1016/j.addr.2015.01.006. Epub 2015 Jan 24.
Abstract
摘要
相似文献
1
Tissue engineering and regenerative medicine: bench to bedside in urology. Preface.
Adv Drug Deliv Rev. 2015 Mar;82-83:v-vii. doi: 10.1016/j.addr.2015.01.006. Epub 2015 Jan 24.
2
Biomaterials and Regenerative Medicine in Urology.
Adv Exp Med Biol. 2018;1107:189-198. doi: 10.1007/5584_2017_139.
3
[Tissue engineering in urology, new approaches for urinary bladder reconstruction].
Tsitologiia. 2015;57(1):14-8.
4
Emerging Translation of Regenerative Therapies.
Clin Pharmacol Ther. 2017 Jan;101(1):28-30. doi: 10.1002/cpt.549. Epub 2016 Nov 26.
5
Tissue engineering and regenerative medicine: recent innovations and the transition to translation.
Tissue Eng Part B Rev. 2013 Feb;19(1):1-13. doi: 10.1089/ten.TEB.2012.0723.
6
Regenerative medicine as a new therapeutic strategy for lower urinary tract dysfunction.
Int J Urol. 2013 Jul;20(7):670-5. doi: 10.1111/iju.12137. Epub 2013 Apr 17.
7
Regenerative medicine primer.
Mayo Clin Proc. 2013 Jul;88(7):766-75. doi: 10.1016/j.mayocp.2013.04.017.
8
Prospects for translational regenerative medicine.
Biotechnol Adv. 2012 May-Jun;30(3):658-72. doi: 10.1016/j.biotechadv.2011.11.005. Epub 2011 Nov 27.
9
Regenerative medicine for urological tissues: Updated review 2018.
Int J Urol. 2018 Sep;25(9):788-791. doi: 10.1111/iju.13762. Epub 2018 Jul 31.
10
Cardiac cell therapy: bench or bedside?
Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):403. doi: 10.1038/ncpcardio0927.
引用本文的文献
1
Three-Dimensional Printing/Bioprinting and Cellular Therapies for Regenerative Medicine: Current Advances.
J Funct Biomater. 2025 Jan 16;16(1):28. doi: 10.3390/jfb16010028.
2
Extracellular matrix stiffness aggravates urethral stricture through Igfbp3/Smad pathway.
Sci Rep. 2023 Aug 31;13(1):14315. doi: 10.1038/s41598-023-41584-6.
3
Onlay Repair Technique for the Management of Ureteral Strictures: A Comprehensive Review.
Biomed Res Int. 2020 Jul 27;2020:6178286. doi: 10.1155/2020/6178286. eCollection 2020.
4
Feasibility of Polycaprolactone Scaffolds Fabricated by Three-Dimensional Printing for Tissue Engineering of Tunica Albuginea.
World J Mens Health. 2018 Jan;36(1):66-72. doi: 10.5534/wjmh.17025. Epub 2017 Oct 25.
5
Biofabrication and biomaterials for urinary tract reconstruction.
Res Rep Urol. 2017 May 10;9:79-92. doi: 10.2147/RRU.S127209. eCollection 2017.
本文引用的文献
1
Wound healing in urology.
Adv Drug Deliv Rev. 2015 Mar;82-83:93-105. doi: 10.1016/j.addr.2014.12.002. Epub 2014 Dec 9.
2
From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
Adv Drug Deliv Rev. 2015 Mar;82-83:192-6. doi: 10.1016/j.addr.2014.12.001. Epub 2014 Dec 7.
3
Biomatrices for bladder reconstruction.
Adv Drug Deliv Rev. 2015 Mar;82-83:47-63. doi: 10.1016/j.addr.2014.11.020. Epub 2014 Dec 2.
4
Acellular matrix in urethral reconstruction.
Adv Drug Deliv Rev. 2015 Mar;82-83:38-46. doi: 10.1016/j.addr.2014.11.019. Epub 2014 Dec 2.
5
Tissue engineering in urothelium regeneration.
Adv Drug Deliv Rev. 2015 Mar;82-83:64-8. doi: 10.1016/j.addr.2014.11.021. Epub 2014 Dec 2.
6
Slings for urinary incontinence and the application of cell-based therapy.
Adv Drug Deliv Rev. 2015 Mar;82-83:22-30. doi: 10.1016/j.addr.2014.11.006. Epub 2014 Nov 22.
7
External physical and biochemical stimulation to enhance skeletal muscle bioengineering.
Adv Drug Deliv Rev. 2015 Mar;82-83:168-175. doi: 10.1016/j.addr.2014.10.021. Epub 2014 Oct 22.
8
Regenerative medicine for the treatment of reproductive system disorders: current and potential options.
Adv Drug Deliv Rev. 2015 Mar;82-83:145-52. doi: 10.1016/j.addr.2014.10.019. Epub 2014 Oct 23.
9
Stress urinary incontinence animal models as a tool to study cell-based regenerative therapies targeting the urethral sphincter.
Adv Drug Deliv Rev. 2015 Mar;82-83:106-16. doi: 10.1016/j.addr.2014.10.018. Epub 2014 Oct 23.
10
Potential of stem cell treatment in detrusor dysfunction.
Adv Drug Deliv Rev. 2015 Mar;82-83:117-22. doi: 10.1016/j.addr.2014.10.017. Epub 2014 Oct 23.
Zotero 插件